Redox Revolution

FDA To Review 12 Peptides: What It Means Moving Forward

33 min · I går
episode FDA To Review 12 Peptides: What It Means Moving Forward cover

Description

The FDA recently announced it will review the safety and efficacy of a number of powerful peptides. In 2023, based on safety concerns and reports that providers were treating patients irresponsibly, the FDA assigned a number of peptides for Category 2, effectively banning US pharmacies from compounding them. Today, Dr. Seeds addresses the why, the how, and the what’s next. Learn more about SSRP Institute [https://ssrpinstitute.org/]  Follow for more! Instagram: @williamseedsmd [https://www.instagram.com/williamaseedsmd/] | @redoxmedicalgroup [https://www.instagram.com/redoxmedicalgroup/] Youtube: Subscribe Here [https://www.youtube.com/channel/UCqECEb71Ybc-kPtg7ITtuAw?sub_confirmation=1]

Comments

0

Be the first to comment

Sign up now and become a member of the Redox Revolution community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

66 episodes